Raymond J. Henley Iii

Array ( [id] => 1470353 [patent_doc_number] => 06407128 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Method for increasing the bioavailability of metaxalone' [patent_app_type] => B1 [patent_app_number] => 09/998206 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2857 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407128.pdf [firstpage_image] =>[orig_patent_app_number] => 09998206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420798 [patent_doc_number] => 06506774 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Use of orexin receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/913230 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3411 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506774.pdf [firstpage_image] =>[orig_patent_app_number] => 09913230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6209987 [patent_doc_number] => 20020072505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'METHOD OF TREATING AIRWAY DISEASES WITH COMBINED ADMINISTRATION OF A2B AND A3 ADENOSINE RECEPTOR ANTAGONISTS' [patent_app_type] => new [patent_app_number] => 09/997948 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3984 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072505.pdf [firstpage_image] =>[orig_patent_app_number] => 09997948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401120 [patent_doc_number] => 06531582 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => '2-O-(9z,12z-octadecadienoyl)-3-O--D-galactopyranosyl-(1-6)-O--D-galactopyranosylglycerol and pharmaceutical composition containing the same' [patent_app_type] => B1 [patent_app_number] => 09/995617 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 9010 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531582.pdf [firstpage_image] =>[orig_patent_app_number] => 09995617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716517 [patent_doc_number] => 20030027865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Method for isolating high-purified unsaturated fatty acids using crystallization' [patent_app_type] => new [patent_app_number] => 09/996544 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5548 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027865.pdf [firstpage_image] =>[orig_patent_app_number] => 09996544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474949 [patent_doc_number] => 06387886 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic' [patent_app_type] => B1 [patent_app_number] => 09/868299 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8496 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387886.pdf [firstpage_image] =>[orig_patent_app_number] => 09868299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589283 [patent_doc_number] => 06482811 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions' [patent_app_type] => B1 [patent_app_number] => 09/869940 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20072 [patent_no_of_claims] => 261 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482811.pdf [firstpage_image] =>[orig_patent_app_number] => 09869940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131238 [patent_doc_number] => 20020077274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 09/989672 [patent_app_country] => US [patent_app_date] => 2001-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5932 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077274.pdf [firstpage_image] =>[orig_patent_app_number] => 09989672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725624 [patent_doc_number] => 20030207936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof' [patent_app_type] => new [patent_app_number] => 10/343780 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15053 [patent_no_of_claims] => 153 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207936.pdf [firstpage_image] =>[orig_patent_app_number] => 10343780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348999 [patent_doc_number] => 06579905 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes' [patent_app_type] => B1 [patent_app_number] => 09/988104 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 956 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579905.pdf [firstpage_image] =>[orig_patent_app_number] => 09988104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845286 [patent_doc_number] => 20020132781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Combination and method of treatment of cancer utilizing a COX-2 inhibitor and A 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase inhibitor' [patent_app_type] => new [patent_app_number] => 09/997490 [patent_app_country] => US [patent_app_date] => 2001-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18568 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132781.pdf [firstpage_image] =>[orig_patent_app_number] => 09997490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225393 [patent_doc_number] => 20040072852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia' [patent_app_type] => new [patent_app_number] => 10/432402 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4411 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072852.pdf [firstpage_image] =>[orig_patent_app_number] => 10432402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177879 [patent_doc_number] => 20020156052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'DELTA AGONIST ANALGESICS' [patent_app_type] => new [patent_app_number] => 10/059953 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5490 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156052.pdf [firstpage_image] =>[orig_patent_app_number] => 10059953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467303 [patent_doc_number] => 06458795 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Method and composition for treatment of irritable bowel disease' [patent_app_type] => B1 [patent_app_number] => 09/987694 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11190 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458795.pdf [firstpage_image] =>[orig_patent_app_number] => 09987694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379006 [patent_doc_number] => 20040028691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Fat composition for oral or enternal administraiton and hexacosanoic acid depressant' [patent_app_type] => new [patent_app_number] => 10/415412 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5271 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028691.pdf [firstpage_image] =>[orig_patent_app_number] => 10415412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053317 [patent_doc_number] => 06858646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Neuroprotective composition and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/021735 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 10708 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858646.pdf [firstpage_image] =>[orig_patent_app_number] => 10021735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291842 [patent_doc_number] => 20020055520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist' [patent_app_type] => new [patent_app_number] => 10/003614 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1263 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055520.pdf [firstpage_image] =>[orig_patent_app_number] => 10003614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829201 [patent_doc_number] => 20020068719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders' [patent_app_type] => new [patent_app_number] => 10/003972 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6945 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068719.pdf [firstpage_image] =>[orig_patent_app_number] => 10003972 [rel_patent_id] =>[rel_patent_doc_number] =>)